PREMAL LULLA to Combined Modality Therapy
This is a "connection" page, showing publications PREMAL LULLA has written about Combined Modality Therapy.
Connection Strength
0.326
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
Score: 0.137
-
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. Cancer J. 2019 May/Jun; 25(3):199-207.
Score: 0.119
-
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol. 2020 11 10; 38(32):3794-3804.
Score: 0.032
-
Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors. Int J Clin Oncol. 2014 Oct; 19(5):822-8.
Score: 0.020
-
Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J Clin Oncol. 2011 Dec; 16(6):722-5.
Score: 0.017